30 related articles for article (PubMed ID: 12881195)
1. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
Denning DW; Warn P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
[TBL] [Abstract][Full Text] [Related]
2. Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin.
Day TP; Sil D; Shukla NM; Anbanandam A; Day VW; David SA
Mol Pharm; 2011 Feb; 8(1):297-301. PubMed ID: 21141891
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of different formulations of nystatin in an experimental model of oral candidiasis in sialoadenectomized rats.
Pérez-Sayáns M; Beiro-Fuentes R; Otero-Rey EM; Chamorro-Petronacci CM; Gándara-Vila P; Somoza-Martín JM; García-García A; Blanco-Carrión A
J Dent Sci; 2021 Jan; 16(1):123-130. PubMed ID: 33384788
[TBL] [Abstract][Full Text] [Related]
4. Correction: New piericidin rhamnosides as potentiators of amphotericin B activity against Candida albicans produced by actinomycete strain TMPU-A0287.
Yagi A; Yamaguchi Y; Kawasaki K; Usui E; Yamazaki H; Uchida R
J Antibiot (Tokyo); 2023 Nov; 76(11):689. PubMed ID: 37735482
[No Abstract] [Full Text] [Related]
5. Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.
Farazuddin M; Dua B; Zia Q; Khan AA; Joshi B; Owais M
Int J Nanomedicine; 2014; 9():1139-52. PubMed ID: 24627632
[TBL] [Abstract][Full Text] [Related]
6. Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles.
Farazuddin M; Sharma B; Khan AA; Joshi B; Owais M
Int J Nanomedicine; 2012; 7():35-47. PubMed ID: 22275821
[TBL] [Abstract][Full Text] [Related]
7. Potential of diallyl sulfide bearing pH-sensitive liposomes in chemoprevention against DMBA-induced skin papilloma.
Khan A; Shukla Y; Kalra N; Alam M; Ahmad MG; Hakim SR; Owais M
Mol Med; 2007; 13(7-8):443-51. PubMed ID: 17622315
[TBL] [Abstract][Full Text] [Related]
8. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.
Evdoridou J; Roilides E; Bibashi E; Kremenopoulos G
Infection; 1997; 25(2):112-6. PubMed ID: 9108188
[TBL] [Abstract][Full Text] [Related]
9. Management of Candida species infections in critically ill patients.
Eggimann P; Garbino J; Pittet D
Lancet Infect Dis; 2003 Dec; 3(12):772-85. PubMed ID: 14652203
[TBL] [Abstract][Full Text] [Related]
10. Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B.
Khan MA; Syed FM; Nasti HT; Saima Dagger K; Haq W; Shehbaz A; Owais M
J Drug Target; 2003 Feb; 11(2):93-9. PubMed ID: 12881195
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis.
Masood AK; Faisal SM; Haque W; Owais M
J Drug Target; 2002 May; 10(3):185-92. PubMed ID: 12075819
[TBL] [Abstract][Full Text] [Related]
13. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice.
Khan MA; Firoz A; Jabeen R; Mohammad O
J Drug Target; 2004; 12(7):425-33. PubMed ID: 15621667
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
